Cite
Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in
MLA
Emrah, Ruh, et al. “Extended-Spectrum β-Lactamase, Plasmid-Mediated AmpC β-Lactamase, Fluoroquinolone Resistance, and Decreased Susceptibility to Carbapenems In.” Antimicrobial Resistance and Infection Control, vol. 8, Nov. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........0e922a0b40367dc30a453f5f046ab20e&authtype=sso&custid=ns315887.
APA
Emrah, R., Jonathan, Z., Kujtesa, H., Arezou, F., Emrah, G., Umut, G., Zafer, E., & Kaya, S. (2018). Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in. Antimicrobial Resistance and Infection Control, 8.
Chicago
Emrah, Ruh, Zakka Jonathan, Hoti Kujtesa, Fekrat Arezou, Guler Emrah, Gazi Umut, Erdogmus Zafer, and Suer Kaya. 2018. “Extended-Spectrum β-Lactamase, Plasmid-Mediated AmpC β-Lactamase, Fluoroquinolone Resistance, and Decreased Susceptibility to Carbapenems In.” Antimicrobial Resistance and Infection Control 8 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........0e922a0b40367dc30a453f5f046ab20e&authtype=sso&custid=ns315887.